3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Rectal Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Myocarditis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Extranodal NK-T-Cell
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma in Situ
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
X-Rays
8
Specimen Handling
8
Cyclophosphamide
8
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
6
fludarabine
5
cabozantinib
5
Gemcitabine
5
Biopsy
5
Nuclear Medicine Department, Hospital
4
Methotrexate
4
Doxorubicin
4
fludarabine phosphate
3
Ifosfamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
olaparib
2
mifamurtide
2
larotrectinib
2
ivosidenib
2
irinotecan sucrosofate
2
ensartinib
2
atezolizumab
2
Vincristine
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Tomography, X-Ray Computed
×
90 days
×
Clear all
No trials found.